The study was a mixed (qualitative and quantitative) cross-sectional study carried out in 4 purposely selected sentinel sites using GeneXpert to test multi-Drug Resistant Tuberculosis. The updated guidelines for evaluating surveillance systems were used to assess the system attributes and system operations. We interviewed 7 clinicians, and 2 national and 16 district stakeholders.MDR-TB notification and laboratory registers were reviewed, and content analysis was performed on completeness, timeliness, and data quality.
